Spoken Alpha
ASRT
Assertio Holdings, Inc.
Overview
Assertio Holdings, Inc is a Healthcare company operating in Drug Manufacturers - Specialty & Generic with a $151.9M market cap.
Most recent reported earnings: Q2 FY2026 (Aug 9, 2026).
20 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Management language signature
Disclosures
Investor Relations
Extracted from Unknown source, 2026-06-21.
Transcripts
Recent earnings calls
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
- Q4 FY2025Earnings2026-03-1612 Q&A exchanges
- Q3 FY2025Earnings2025-11-107 Q&A exchanges
- Q2 FY2025Earnings2025-08-1112 Q&A exchanges
- Q1 FY2025Earnings2025-05-1220 Q&A exchanges
- Q4 FY2024Earnings2025-03-1219 Q&A exchanges
- Q3 FY2024Earnings2024-11-1115 Q&A exchanges
- Q2 FY2024Earnings2024-08-0715 Q&A exchanges
- Q1 FY2024Earnings2024-05-0611 Q&A exchanges
- Q4 FY2023Earnings2024-03-1114 Q&A exchanges
- Q3 FY2023Earnings2023-11-0821 Q&A exchanges
- Q2 FY2023Earnings2023-08-0313 Q&A exchanges
- Q1 FY2023Earnings2023-05-0923 Q&A exchanges
- Q4 FY2022Earnings2023-03-0826 Q&A exchanges
- Q3 FY2022Earnings2022-11-0820 Q&A exchanges
- Q2 FY2022Earnings2022-08-0821 Q&A exchanges
- Q1 FY2022Earnings2022-05-0911 Q&A exchanges
- Q4 FY2021Earnings2022-03-0916 Q&A exchanges
- Q3 FY2021Earnings2021-11-046 Q&A exchanges
- Q2 FY2021Earnings2021-08-051 Q&A exchange
- Q1 FY2021Earnings2021-05-068 Q&A exchanges
History
Earnings history
- Q2 FY20262026-08-09EPS— vs $-1.10—Rev— vs ——EODHD
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q2 FY2026 | 2026-08-09 | — | $-1.10 | — | — | — | — | EODHD |
Source: EODHD. ASRT reported actuals as published; sparse fields render as —.
Track Record
SampleSpoken Alpha tracks ASRT's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Misses consensus 10/10 quarters
SampleRepeated misses without a guidance reset suggest management is structurally optimistic relative to operating reality. Track whether next-quarter guidance is being benchmarked off the prior miss or the prior plan.
Missed in 4 of the last 4 quarters
SampleRecent misses matter more than long-window beat rate — the trailing 12 months drives the analyst model and the next-print bar.
Quarterly beats & misses
Sample| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2025 | $2.85 | $3.72 | -23.4% | -2.7% | -2.3% |
| Q4 FY2025 | $2.93 | $3.87 | -24.3% | +1.5% | +3.2% |
| Q3 FY2025 | $3.22 | $3.91 | -17.7% | +2.3% | -0.1% |
| Q2 FY2025 | $2.83 | $3.73 | -24.2% | +5.0% | +4.6% |
| Q1 FY2024 | $3.12 | $3.93 | -20.6% | -0.5% | +1.9% |
| Q4 FY2024 | $2.77 | $3.83 | -27.7% | +0.4% | -0.1% |
| Q3 FY2024 | $2.90 | $3.93 | -26.2% | -1.9% | -0.6% |
| Q2 FY2024 | $3.27 | $3.99 | -18.0% | -1.0% | 0.0% |
| Q1 FY2023 | $3.43 | $3.94 | -13.0% | +2.0% | +4.0% |
| Q4 FY2023 | $3.00 | $3.99 | -24.8% | +7.7% | +9.1% |
Guidance change history
Sample- Q1 FY2025Lowered2025-04-15
- Q4 FY2025Lowered2025-13-15
- Q3 FY2025Lowered2025-10-15
- Q2 FY2025Lowered2025-07-15
- Q1 FY2024Lowered2024-04-15
- Q4 FY2024Lowered2024-13-15
- Q3 FY2024Lowered2024-10-15
- Q2 FY2024Lowered2024-07-15
Top executives
SampleSpoken Alpha builds an accountability record per executive — how the person's own guidance, language, and reactions have evolved across every call they've appeared on. The one-liners below are illustrative placeholder data pending the deviation v1 work. Click any name for the full role timeline and call appearance history.
- Mark L ReisenauerCEO7 mo2 callsCurrentSample
CEO since 2025 • 1/2 beats (50%) • guidance suspended Q2 FY2025
- Brendan P O'GradyCEO1 yr 7 mo5 callsCurrentSample
CEO since 2024 • 2/4 beats (50%) • last guidance raise Q1 FY2025
- Ajay PatelCFO1 yr 1 mo10 callsCurrentSample
CFO since 2025 • 1/2 beats (50%) • last guidance cut Q2 FY2025
- Paul SchwichtenbergCOO4 mo15 callsCurrentSample
COO since 2026 • 1/2 beats (50%) • last call held guidance Q3 FY2025
- Sam SchlessingerEVP, General Counsel1 yr 1 mono recorded callsCurrentSample
DIVISION_HEAD since 2025 • 1/2 beats (50%) • last guidance cut Q2 FY2025
- Mary E PietrygaSVP, CCO0 mono recorded callsFormerSample
OTHER_C_SUITE since 2025 • 2/2 beats (100%) • last guidance raise Q3 FY2025
Peers
Other companies in Healthcare
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
For developers and AI agents
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for ASRT.
$ curl https://api.spokenalpha.com/v1/companies/ASRTFAQ
Frequently asked about ASRT
Where can I find Assertio Holdings, Inc.'s (ASRT) earnings call transcripts?
Spoken Alpha indexes ASRT's earnings call transcripts at https://spokenalpha.com/companies/ASRT. Each call links to attributed speakers and parsed analyst Q&A. Assertio Holdings, Inc.'s own investor relations page is at https://investor.assertiotx.com/overview/default.aspx.
When was Assertio Holdings, Inc.'s most recent earnings call?
Assertio Holdings, Inc. (ASRT) held its most recent earnings call on 2026-03-16, covering fiscal Q4 2025.
What sector is ASRT in?
Assertio Holdings, Inc. (ASRT) operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).